Cerba Healthcare Defers Debt Restructuring Plan Pending French Government Subsidy Update

Apr 29, 2026 10:44 UTC

EQT

Short term

EQT-backed Cerba Healthcare has informed creditors that its strategy for managing €5 billion in debt is contingent on upcoming government decisions. The company expects clarity on private laboratory subsidies by late May or June.

Total debt pile stands at €5 billion ($5.85 billion)
Restructuring timeline depends on French government subsidy updates
Official government guidance expected late May or June
Communication delivered to term loan and bond holders

Cerba Healthcare, a portfolio company of EQT AB, has notified its bondholders and term loan creditors that the timeline for its debt repayment plan is now tied to French regulatory updates. The company is currently grappling with a substantial debt load totaling €5 billion ($5.85 billion). The resolution of this leverage depends heavily on the French government's forthcoming stance on subsidies provided to private laboratory firms. During a call held on Monday, Cerba officials indicated that a comprehensive plan to tackle the debt pile will be presented after the government provides its update, which is anticipated in late May or June. This delay places creditors in a holding pattern, shifting the focus to the French government's fiscal policy regarding healthcare infrastructure. The outcome of these subsidy discussions will likely determine the viability of Cerba's restructuring efforts and the eventual recovery rates for its lenders.